Interferon-γ for the treatment of metastatic renal cancer: Dose-dependent stimulation and downregulation of beta2 microglobulin and neopterin responses
Authors:
- G. GastlGGG. Gastl
- W.E. AulitzkyWAW.E. Aulitzky
- K. NachbaurKNK. Nachbaur
- B. LanskeBLB. Lanske
- G. KemmlerGKG. Kemmler
- R. FlenerRFR. Flener
- J. FrickJFJ. Frick
- C. HuberCHC. Huber
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Immunobiology
- Vol. 176 (1-2) , 85-95
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cytokines in the Control of Beta-2 Microglobulin Release. II. In vivo Studies with Recombinant Interferons and AntigensImmunobiology, 1988
- Cytokines in the Control of Beta-2 Microglobulin Release. I. In vitro Studies on Various Haemopoietic CellsImmunobiology, 1988
- Immunotoxicology and the new biotechnologyImmunology Today, 1987
- RELATIONSHIP OF INTERFERON-GAMMA AND NEOPTERIN LEVELS DURING STIMULATION WITH ALLOANTIGENS IN VIVO AND IN VITROTransplantation, 1986
- Activation of 2?,5?-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: Dependence of biological effect on administration routeCancer Chemotherapy and Pharmacology, 1986
- Distribution of ‘Free’ and HLA‐associated Human β2‐Microglobulin in Some Plasma Membranes and Biological FluidsScandinavian Journal of Immunology, 1980
- Beta‐2‐microglobulin review: Its relevance in clinical oncologyMedical and Pediatric Oncology, 1980
- β2-Microglobulin and the Major Histocompatibility Complex1977
- Radioimmunoassay of β2-MicroglobulinScandinavian Journal of Clinical and Laboratory Investigation, 1975
- Pteridine CofactorsAnnual Review of Biochemistry, 1967